A Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts.

Trial Profile

A Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Mar 2014

At a glance

  • Drugs Imiquimod (Primary)
  • Indications Genital warts
  • Focus Registrational; Therapeutic Use
  • Sponsors Graceway Pharmaceuticals
  • Most Recent Events

    • 19 Jul 2011 Company added in the association field, additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
    • 10 Jul 2010 Results from a pooled analysis of phase III trials evaluating the use of imiquimod for the treatment of genital warts have been presented at the Human Papillomavirus Conference, Montreal, 3-8 Jul 2010, according to a Graceway media release.
    • 29 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top